ASML (AS:ASML) reported first-quarter 2025 net sales of €7.74 billion and net income of €2.36 billion, aligning with its prior guidance. The Dutch chip equipment maker maintained its full-year revenue forecast between €30 billion and €35 billion, citing continued demand growth driven by artificial intelligence.
The gross margin improved to 54%, exceeding expectations due to a favorable EUV product mix and milestone achievements. However, gross profit fell to €4.2 billion from €4.8 billion in Q4 2024, and basic earnings per share declined to €6 from €6.85.
Net bookings dropped to €3.9 billion, including €1.2 billion from EUV lithography systems, down from €7.1 billion the previous quarter. ASML shipped 73 new lithography systems and 4 used ones, compared to 119 and 13, respectively, in Q4.
Installed Base Management revenue, which includes services and upgrades, totaled €2 billion, slightly lower than the previous quarter’s €2.1 billion. The company ended the quarter with €9.1 billion in cash and equivalents, down from €12.7 billion.
For Q2 2025, ASML expects sales of €7.2 billion to €7.7 billion, with a gross margin between 50% and 53%. R&D expenses are projected at €1.2 billion, and SG&A at €300 million. The company continues to target a full-year gross margin between 51% and 53%.
CEO Christophe Fouquet noted the shipment of the fifth High NA EUV system and its installation at three customer sites. He added that while AI remains a strong demand driver, recent tariff developments have introduced macroeconomic uncertainty.
ASML plans a 2024 dividend of €6.40 per share, up 4.9% year-over-year, including a proposed final dividend of €1.84. The company also repurchased €2.7 billion in shares during Q1 under its ongoing buyback program.


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



